Press release -
Isansys Named as Finalist for Gore Innovation Center Prize at the world-leading 10th IOT/WT Innovation World Cup®
Isansys Lifecare is proud to announce it has been selected as one of the top four finalists for the Gore Technology Innovation Center Prize for its world-leading wireless patient monitoring technology.
An international panel of judges selected Isansys out of nearly 500 submissions for its level of innovation, marketability, and usability.
Isansys will now compete against three other companies for the Gore Innovation Center Prize on February 5th at the WT | Wearable Technologies Conference 2019 in Munich. Here finalists will present their solutions live on stage and the winners will be announced.
Part of the competition has been opened up to a public vote and Isansys now needs your support to be named the winner.
Voting is now open and you can vote for us here : http://bit.ly/VOTEisansys
Keith Errey, CEO of Isansys, says: “It's a great honour for Isansys to be shortlisted for the Gore Innovation Center prize. This is clear recognition that the work we are doing with hospitals and healthcare providers globally is very much the future of patient monitoring and accurate real-world data collection. If we can now secure the public’s vote for the competition, we can increase global awareness of the Patient Status Engine further, advance its development and build even more valuable alliances with recognized industry partners.”
Isansys has created the Patient Status Engine (PSE), a technologically advanced, all wireless patient monitoring system. A complete ready-built configurable platform, the PSE is also a fully certified Class IIa CE-marked and Class II FDA medical device that monitors patients automatically, continuously and in real-time. Included in the PSE are predictive analytics including Early Warning Scores and condition-specific apps. The PSE is readily integrated with established digital health platforms (EMR’s) and presents the data and predictive scores at the bedside, at centralised remote monitoring stations and on individual clinician’s mobile devices.
The PSE uses wearable sensors including the Isansys’ Lifetouch cardiac monitoring smart patch and the Lifetemp clinical thermometer providing wireless freedom for patients and near ICU quality continuous physiological data to generate robust and clinically validated real-time predictive indicators. These ensure that any deterioration in the condition of the patient is identified quickly allowing care teams to carry out more timely, less traumatic and lower cost interventions.
Isansys is the world's leading digital healthcare company which has developed an innovative patient monitoring platform, enabling early detection of deterioration in patients. We are a business focussed on driving disruptive technologies into hospitals and healthcare organisations globally providing health professionals with the vital tools required to improve patient care and increase clinical performance, ensuring economic value and enhancing patient safety. For further information and to stay updated on our latest news visit www.isansys.com, follow us on Twitter at @isansys or subscribe to our YouTube Channel at www.youtube.com/isansyslifecare